Align Technology Inc (ALGN)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$2.15 (-1.02%)Past Day

About

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Key Insights

  • Share Price

    $207.90
  • Market Cap

    $15.53 Billion
  • Total Outstanding Shares

    74.70 Million Shares
  • Total Employees

    21,805
  • Dividend

    No dividend
  • IPO Date

    January 26, 2001
  • SIC Description

    Orthopedic, Prosthetic & Surgical Appliances & Supplies
  • Homepage

    https://www.aligntech.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow$-189.84 Million
Net Cash Flow From Investing Activities, Continuing$-209.71 Million
Exchange Gains/Losses$-1.00 Million
Net Cash Flow From Financing Activities$-501.72 Million
Net Cash Flow, Continuing$-188.83 Million
Net Cash Flow From Financing Activities, Continuing$-501.72 Million
Net Cash Flow From Investing Activities$-209.71 Million
Net Cash Flow From Operating Activities, Continuing$522.60 Million
Net Cash Flow From Operating Activities$522.60 Million

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Income/Loss From Continuing Operations Before Tax$637.24 Million
Preferred Stock Dividends And Other Adjustments$0.00
Research and Development$354.95 Million
Operating Expenses$2.11 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income Tax Expense/Benefit$190.21 Million
Selling, General, and Administrative Expenses$1.71 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Available To Common Stockholders, Basic$447.03 Million
Operating Income/Loss$639.07 Million
Revenues$3.94 Billion
Net Income/Loss$447.03 Million
Nonoperating Income/Loss$-20.02 Million
Income Tax Expense/Benefit, Deferred$27.55 Million
Diluted Earnings Per Share$5.89
Cost Of Revenue$1.19 Billion
Diluted Average Shares$151.86 Million
Income/Loss From Continuing Operations After Tax$447.03 Million
Net Income/Loss Attributable To Parent$447.03 Million
Costs And Expenses$3.31 Billion
Benefits Costs and Expenses$3.31 Billion
Basic Earnings Per Share$5.90
Basic Average Shares$151.50 Million
Gross Profit$2.75 Billion

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Fixed Assets$1.28 Billion
Other Current Assets$2.06 Billion
Equity Attributable To Parent$3.76 Billion
Liabilities And Equity$6.16 Billion
Other Non-current Assets$2.35 Billion
Intangible Assets$115.70 Million
Current Liabilities$2.04 Billion
Noncurrent Liabilities$360.30 Million
Inventory$259.49 Million
Wages$232.05 Million
Current Assets$2.41 Billion
Other Current Liabilities$1.70 Billion
Equity Attributable To Noncontrolling Interest$0.00
Assets$6.16 Billion
Liabilities$2.40 Billion
Equity$3.76 Billion
Prepaid Expenses$91.26 Million
Accounts Payable$105.79 Million
Noncurrent Assets$3.75 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.